ArticleScientific reports2020

EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma.

Wei-Wei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.